June 18, 2020 / 12:08 PM / a month ago

BRIEF-Lineage Cell Therapeutics Reinitiates Patient Enrollment In Clinical Study Of Opregen

June 18 (Reuters) - Lineage Cell Therapeutics Inc:

* LINEAGE CELL THERAPEUTICS REINITIATES PATIENT ENROLLMENT IN CLINICAL STUDY OF OPREGEN® FOR TREATMENT OF DRY AMD WITH GEOGRAPHIC ATROPHY

* LINEAGE CELL THERAPEUTICS INC - HAS RESTARTED PATIENT ENROLLMENT IN A PHASE 1/2A CLINICAL STUDY OF ITS LEAD PRODUCT CANDIDATE, OPREGEN

* LINEAGE CELL THERAPEUTICS INC - ANTICIPATES IT WILL COMPLETE ENROLLMENT OF LAST 3 PATIENTS IN COHORT 4 OF OPREGEN CLINICAL STUDY IN Q3 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below